Atomistry » Fluorine » PDB 5vd7-5vta » 5vp1
Atomistry »
  Fluorine »
    PDB 5vd7-5vta »
      5vp1 »

Fluorine in PDB 5vp1: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders

Enzymatic activity of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders

All present enzymatic activity of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders:
3.1.4.17;

Protein crystallography data

The structure of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders, PDB code: 5vp1 was solved by I.D.Hoffman, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 1.86
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 165.129, 72.712, 90.061, 90.00, 109.15, 90.00
R / Rfree (%) 22.5 / 24.3

Other elements in 5vp1:

The structure of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders also contains other interesting chemical elements:

Magnesium (Mg) 4 atoms
Zinc (Zn) 3 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders (pdb code 5vp1). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 9 binding sites of Fluorine where determined in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders, PDB code: 5vp1:
Jump to Fluorine binding site number: 1; 2; 3; 4; 5; 6; 7; 8; 9;

Fluorine binding site 1 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 1 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1004

b:31.0
occ:1.00
 F28 A:9GA1004 0.0 31.0 1.0
C27 A:9GA1004 1.4 29.6 1.0
F30 A:9GA1004 2.2 30.3 1.0
F29 A:9GA1004 2.3 31.1 1.0
O26 A:9GA1004 2.3 28.3 1.0
C25 A:9GA1004 2.9 25.9 1.0
C24 A:9GA1004 3.0 25.5 1.0
CG2 A:ILE866 3.3 26.9 1.0
CD1 A:ILE870 3.4 26.1 1.0
CD1 A:LEU770 3.6 24.5 1.0
CD1 A:LEU809 3.6 22.2 1.0
C31 A:9GA1004 4.1 24.2 1.0
CD2 A:HIS773 4.2 24.9 1.0
C23 A:9GA1004 4.2 24.3 1.0
CG A:LEU809 4.3 21.7 1.0
CG A:HIS773 4.5 24.2 1.0
CD2 A:LEU809 4.6 21.4 1.0
CB A:THR805 4.7 21.9 1.0
CG A:LEU770 4.7 24.9 1.0
CB A:LEU770 4.8 23.4 1.0
CB A:HIS773 4.8 23.6 1.0
NE2 A:HIS773 4.8 25.9 1.0
CB A:ILE866 4.8 28.2 1.0
CA A:LEU770 4.8 22.9 1.0
CG2 A:THR805 4.8 22.2 1.0
CG1 A:ILE870 4.9 26.5 1.0

Fluorine binding site 2 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 2 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1004

b:31.1
occ:1.00
 F29 A:9GA1004 0.0 31.1 1.0
C27 A:9GA1004 1.4 29.6 1.0
O26 A:9GA1004 2.3 28.3 1.0
F28 A:9GA1004 2.3 31.0 1.0
F30 A:9GA1004 2.3 30.3 1.0
CB A:HIS773 3.1 23.6 1.0
CG2 A:THR805 3.1 22.2 1.0
CG A:HIS773 3.3 24.2 1.0
C25 A:9GA1004 3.5 25.9 1.0
CB A:THR805 3.6 21.9 1.0
CD2 A:HIS773 3.7 24.9 1.0
ND1 A:HIS773 4.0 25.0 1.0
CA A:LEU770 4.1 22.9 1.0
CD1 A:LEU770 4.1 24.5 1.0
CD1 A:ILE870 4.2 26.1 1.0
C24 A:9GA1004 4.3 25.5 1.0
C31 A:9GA1004 4.4 24.2 1.0
O A:ALA767 4.4 23.3 1.0
OG1 A:THR805 4.5 22.5 1.0
CA A:HIS773 4.5 23.7 1.0
NE2 A:HIS773 4.5 25.9 1.0
O A:ASP769 4.5 22.3 1.0
N A:LEU770 4.6 22.5 1.0
CE1 A:HIS773 4.7 25.6 1.0
CB A:LEU770 4.7 23.4 1.0
CA A:THR805 4.8 21.8 1.0
C A:ASP769 4.8 22.3 1.0
O A:LEU770 4.8 23.5 1.0
O A:HOH1134 4.9 22.0 1.0
C A:LEU770 5.0 23.1 1.0
N A:HIS773 5.0 23.2 1.0
O A:THR768 5.0 21.9 1.0
O A:HOH1182 5.0 22.4 1.0

Fluorine binding site 3 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 3 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1004

b:30.3
occ:1.00
 F30 A:9GA1004 0.0 30.3 1.0
C27 A:9GA1004 1.4 29.6 1.0
F28 A:9GA1004 2.2 31.0 1.0
O26 A:9GA1004 2.3 28.3 1.0
F29 A:9GA1004 2.3 31.1 1.0
C25 A:9GA1004 2.8 25.9 1.0
C31 A:9GA1004 3.2 24.2 1.0
CB A:THR805 3.2 21.9 1.0
CG2 A:THR805 3.4 22.2 1.0
C24 A:9GA1004 3.7 25.5 1.0
CA A:THR805 3.7 21.8 1.0
CG A:LEU809 3.7 21.7 1.0
CD1 A:LEU809 3.8 22.2 1.0
O A:THR805 3.9 23.2 1.0
CD1 A:ILE870 4.1 26.1 1.0
CD2 A:LEU809 4.1 21.4 1.0
C A:THR805 4.2 22.4 1.0
C32 A:9GA1004 4.3 23.6 1.0
OG1 A:THR805 4.4 22.5 1.0
CB A:ASP808 4.5 20.3 1.0
C23 A:9GA1004 4.7 24.3 1.0
OD2 A:ASP808 4.8 20.8 1.0
C22 A:9GA1004 4.9 23.2 1.0
O A:THR768 5.0 21.9 1.0

Fluorine binding site 4 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 4 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1003

b:31.2
occ:1.00
 F28 B:9GA1003 0.0 31.2 1.0
C27 B:9GA1003 1.4 29.5 1.0
F29 B:9GA1003 2.2 31.1 1.0
F30 B:9GA1003 2.3 30.1 1.0
O26 B:9GA1003 2.3 28.5 1.0
C25 B:9GA1003 2.9 26.2 1.0
C24 B:9GA1003 3.1 26.4 1.0
CG2 B:ILE866 3.2 29.9 1.0
CD1 B:ILE870 3.4 29.0 1.0
CD1 B:LEU770 3.6 28.2 1.0
CD1 B:LEU809 3.6 24.9 1.0
CG2 B:THR805 3.9 31.1 1.0
C31 B:9GA1003 4.0 25.3 1.0
CD2 B:HIS773 4.2 28.5 1.0
C23 B:9GA1003 4.3 25.1 1.0
CG B:LEU809 4.4 24.2 1.0
CG B:HIS773 4.5 28.1 1.0
CD2 B:LEU809 4.6 23.7 1.0
CB B:ILE866 4.7 30.4 1.0
CG B:LEU770 4.7 28.4 1.0
NE2 B:HIS773 4.8 28.8 1.0
CB B:HIS773 4.8 28.1 1.0
CB B:LEU770 4.8 27.3 1.0
CG1 B:ILE870 4.8 29.5 1.0
CA B:LEU770 4.8 27.1 1.0
C32 B:9GA1003 5.0 23.7 1.0

Fluorine binding site 5 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 5 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 5 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1003

b:31.1
occ:1.00
 F29 B:9GA1003 0.0 31.1 1.0
C27 B:9GA1003 1.4 29.5 1.0
O26 B:9GA1003 2.2 28.5 1.0
F28 B:9GA1003 2.2 31.2 1.0
F30 B:9GA1003 2.3 30.1 1.0
CB B:HIS773 3.0 28.1 1.0
CG B:HIS773 3.3 28.1 1.0
CG2 B:THR805 3.3 31.1 1.0
OG1 B:THR805 3.4 30.7 1.0
C25 B:9GA1003 3.5 26.2 1.0
CD2 B:HIS773 3.7 28.5 1.0
CA B:LEU770 4.0 27.1 1.0
CB B:THR805 4.0 28.8 1.0
ND1 B:HIS773 4.0 28.3 1.0
CD1 B:LEU770 4.0 28.2 1.0
CD1 B:ILE870 4.2 29.0 1.0
C24 B:9GA1003 4.3 26.4 1.0
C31 B:9GA1003 4.3 25.3 1.0
O B:ALA767 4.5 24.9 1.0
O B:ASP769 4.5 27.0 1.0
N B:LEU770 4.5 26.7 1.0
NE2 B:HIS773 4.5 28.8 1.0
CA B:HIS773 4.5 29.0 1.0
CB B:LEU770 4.7 27.3 1.0
CE1 B:HIS773 4.7 28.9 1.0
C B:ASP769 4.7 26.5 1.0
O B:LEU770 4.8 28.5 1.0
C B:LEU770 4.9 27.8 1.0
O B:HOH1144 4.9 23.3 1.0
CA B:THR805 4.9 26.4 1.0
O B:THR768 4.9 24.6 1.0
N B:HIS773 5.0 28.4 1.0
CG B:LEU770 5.0 28.4 1.0

Fluorine binding site 6 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 6 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 6 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1003

b:30.1
occ:1.00
 F30 B:9GA1003 0.0 30.1 1.0
C27 B:9GA1003 1.4 29.5 1.0
O26 B:9GA1003 2.2 28.5 1.0
F28 B:9GA1003 2.3 31.2 1.0
F29 B:9GA1003 2.3 31.1 1.0
C25 B:9GA1003 2.7 26.2 1.0
CG2 B:THR805 2.9 31.1 1.0
C31 B:9GA1003 3.1 25.3 1.0
OG1 B:THR805 3.6 30.7 1.0
CB B:THR805 3.6 28.8 1.0
C24 B:9GA1003 3.7 26.4 1.0
CD1 B:LEU809 3.8 24.9 1.0
CG B:LEU809 3.8 24.2 1.0
CA B:THR805 3.8 26.4 1.0
O B:THR805 3.9 25.3 1.0
CD1 B:ILE870 4.1 29.0 1.0
CD2 B:LEU809 4.2 23.7 1.0
C32 B:9GA1003 4.2 23.7 1.0
C B:THR805 4.3 25.6 1.0
CB B:ASP808 4.5 22.0 1.0
C23 B:9GA1003 4.7 25.1 1.0
OD2 B:ASP808 4.7 22.6 1.0
O B:THR768 4.9 24.6 1.0
C22 B:9GA1003 4.9 24.4 1.0

Fluorine binding site 7 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 7 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 7 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
C:F1003

b:31.6
occ:1.00
 F28 C:9GA1003 0.0 31.6 1.0
C27 C:9GA1003 1.4 30.6 1.0
F30 C:9GA1003 2.3 31.7 1.0
F29 C:9GA1003 2.3 30.1 1.0
O26 C:9GA1003 2.3 29.7 1.0
C25 C:9GA1003 2.9 27.2 1.0
C24 C:9GA1003 3.1 27.3 1.0
CG2 C:ILE866 3.2 29.9 1.0
CD1 C:ILE870 3.4 27.1 1.0
CD1 C:LEU809 3.6 23.1 1.0
CD1 C:LEU770 3.6 29.5 1.0
C31 C:9GA1003 4.0 25.6 1.0
CD2 C:HIS773 4.2 31.6 1.0
C23 C:9GA1003 4.3 26.7 1.0
CG C:LEU809 4.4 22.1 1.0
CG C:HIS773 4.5 30.4 1.0
CD2 C:LEU809 4.6 22.3 1.0
CB C:ILE866 4.7 30.8 1.0
CB C:THR805 4.7 22.4 1.0
CG C:LEU770 4.8 29.5 1.0
NE2 C:HIS773 4.8 32.4 1.0
CB C:HIS773 4.8 29.4 1.0
CB C:LEU770 4.8 28.2 1.0
CG1 C:ILE870 4.8 27.3 1.0
CA C:LEU770 4.9 27.7 1.0
CG2 C:THR805 4.9 22.3 1.0
O C:ILE866 5.0 29.7 1.0
C32 C:9GA1003 5.0 24.9 1.0

Fluorine binding site 8 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 8 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 8 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
C:F1003

b:30.1
occ:1.00
 F29 C:9GA1003 0.0 30.1 1.0
C27 C:9GA1003 1.4 30.6 1.0
O26 C:9GA1003 2.3 29.7 1.0
F28 C:9GA1003 2.3 31.6 1.0
F30 C:9GA1003 2.3 31.7 1.0
CB C:HIS773 3.0 29.4 1.0
CG2 C:THR805 3.2 22.3 1.0
CG C:HIS773 3.3 30.4 1.0
C25 C:9GA1003 3.5 27.2 1.0
CD2 C:HIS773 3.7 31.6 1.0
CB C:THR805 3.7 22.4 1.0
ND1 C:HIS773 4.0 30.6 1.0
CA C:LEU770 4.0 27.7 1.0
CD1 C:LEU770 4.1 29.5 1.0
CD1 C:ILE870 4.2 27.1 1.0
C31 C:9GA1003 4.3 25.6 1.0
C24 C:9GA1003 4.4 27.3 1.0
O C:ALA767 4.4 24.6 1.0
O C:ASP769 4.5 26.4 1.0
N C:LEU770 4.5 26.9 1.0
CA C:HIS773 4.5 29.7 1.0
NE2 C:HIS773 4.5 32.4 1.0
OG1 C:THR805 4.5 22.9 1.0
CE1 C:HIS773 4.7 31.6 1.0
CB C:LEU770 4.7 28.2 1.0
C C:ASP769 4.7 26.8 1.0
O C:LEU770 4.8 29.2 1.0
CA C:THR805 4.9 21.8 1.0
O C:HOH1137 4.9 28.2 1.0
C C:LEU770 4.9 28.7 1.0
N C:HIS773 4.9 29.2 1.0
O C:THR768 4.9 24.6 1.0
O C:HOH1131 5.0 26.4 1.0

Fluorine binding site 9 out of 9 in 5vp1

Go back to Fluorine Binding Sites List in 5vp1
Fluorine binding site 9 out of 9 in the Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 9 of Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4- (Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3- Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor For the Treatment of Cognitive Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
C:F1003

b:31.7
occ:1.00
 F30 C:9GA1003 0.0 31.7 1.0
C27 C:9GA1003 1.4 30.6 1.0
F28 C:9GA1003 2.3 31.6 1.0
O26 C:9GA1003 2.3 29.7 1.0
F29 C:9GA1003 2.3 30.1 1.0
C25 C:9GA1003 2.8 27.2 1.0
C31 C:9GA1003 3.1 25.6 1.0
CB C:THR805 3.2 22.4 1.0
CG2 C:THR805 3.4 22.3 1.0
CD1 C:LEU809 3.7 23.1 1.0
CA C:THR805 3.8 21.8 1.0
C24 C:9GA1003 3.8 27.3 1.0
CG C:LEU809 3.8 22.1 1.0
O C:THR805 3.9 22.5 1.0
CD1 C:ILE870 4.0 27.1 1.0
CD2 C:LEU809 4.2 22.3 1.0
C32 C:9GA1003 4.2 24.9 1.0
C C:THR805 4.3 22.2 1.0
OG1 C:THR805 4.4 22.9 1.0
CB C:ASP808 4.6 21.8 1.0
C23 C:9GA1003 4.7 26.7 1.0
OD2 C:ASP808 4.8 24.6 1.0
O C:THR768 4.9 24.6 1.0
C22 C:9GA1003 4.9 25.5 1.0

Reference:

S.Mikami, M.Kawasaki, S.Ikeda, N.Negoro, S.Nakamura, I.Nomura, T.Ashizawa, H.Kokubo, I.D.Hoffman, H.Zou, H.Oki, N.Uchiyama, Y.Hiura, M.Miyamoto, Y.Itou, M.Nakashima, H.Iwashita, T.Taniguchi. Discovery of A Novel Series of Pyrazolo[1,5-A]Pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different From N-((1S)-1-(3-Fluoro-4-(Trifluoromethoxy)Phenyl) -2-Methoxyethyl)-7-Methoxy-2-Oxo-2,3-Dihydropyrido[2, 3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), For the Treatment of Cognitive Disorders. Chem. Pharm. Bull. V. 65 1058 2017.
ISSN: ISSN 1347-5223
PubMed: 29093293
DOI: 10.1248/CPB.C17-00564
Page generated: Tue Jul 15 08:38:37 2025

Last articles

Mg in 7BNR
Mg in 7BNK
Mg in 7BMC
Mg in 7BM9
Mg in 7BM8
Mg in 7BM6
Mg in 7BL4
Mg in 7BL6
Mg in 7BL5
Mg in 7BJT
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy